Drug
Campath 1H
Campath 1H: highest development phase Phase 2, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Campath-1H NCT00071396 | Phase 2 | Chronic Lymphocytic Leukemia |
Latest
No recent events.
Follow Campath 1H on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.